Next, the levels of interleukin 6 (IL6) and lymphocyte subsets in COVID-19 patients from our hospital were analyzed to verify whether there were abnormalities in interleukin and immune cells in COVID-19 patients with myocardial injury. The gene discussed is IL6; the disease is COVID-19.